Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • BlossomHill eyes $112M IPO harvest to bankroll potential Tagrisso challenger

BlossomHill eyes $112M IPO harvest to bankroll potential Tagrisso challenger

August 3, 2026Posted inBiotechnology

BlossomHill Therapeutics plans to raise $111.7 million to fund the clinical journey of its potential challenger to Tagrisso.

Post navigation

Previous Post
how-the-brain-sustains-motivation How the Brain Sustains Motivation
Next Post
Foundation Model Uses Sleep Data to Predict Health Risks and Clinical Outcomes foundation-model-uses-sleep-data-to-predict-health-risks-and-clinical-outcomes

Recent Posts

  • From Oil Mill Waste to Superfood: The Hidden Protein Goldmine in Seed Byproducts
  • Spin and Shaky Reporting Riddle the Abstracts of Oral Mucositis Trials
  • How the Body’s Hidden Reserves Could Forecast Heart, Kidney and Metabolic Disease
  • Hidden Bureaucrats: How Regional Medicare Contractors Quietly Shape Dermatology Care Across America
  • Particle Engineering Takes Center Stage as Pharmaceutical Formulation Science Eyes the Clinic

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top